US-born optometrist, Dr Valarie Jerome, reflects on returning to north east Florida to practise after working in the UK for ...

Myopia is booming. Can we stop the epidemic of short-sightedness?

Glaucoma is often called the “silent thief of sight” because it can slowly damage vision without causing obvious symptoms in ...

The first storms of the monsoon season are on the way. Expect more moisture and lower temperatures this week, according to ...

Bausch + Lomb has abandoned its next great hope in glaucoma after the eye drops flunked a phase 2 study. The eye health company had been evaluating the alpha-2B agonist, dubbed BL1107, in a mid-stage ...

Bausch + Lomb said on Thursday its glaucoma eye drop had missed ​the main goal in a mid-stage ‌trial of replicating visual function improvements observed in a smaller study.

Bausch + Lomb will stop developing a topical eye drop for glaucoma after the drug failed to meet its primary endpoint in a phase 2 study. The company on Thursday said the drug, BL1107, didn't ...

One of the most common things I hear from my Chinese-speaking patients when discussing their glaucoma care is simple and ...

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

Please provide your email address to receive an email when new articles are posted on . Proposed criteria would limit Medicare coverage for iDose TR. The result would be delayed care at a higher cost ...

Lexitas Pharma Services and Ocusun have announced enrollment of the first patient in a pilot study evaluating ZOC2017217, an ...

Active learning puts students at the center of the learning process by encouraging them to engage, reflect, and apply what they’re learning in meaningful ways. Rather than passively receiving ...